Mesenchymal stem cell‐derived extracellular vesicles for the treatment of acute respiratory distress syndrome

• Main Authors: Aswin Abraham, Anna Krasnodembskaya
• Format: Article
• Language: English
• Published: Wiley 2020-01-01
• Series: Stem Cells Translational Medicine
• Subjects: cellular therapy; clinical translation; mesenchymal stem cells (MSCs); respiratory tract
• Online Access: https://doi.org/10.1002/sctm.19-0205

Abstract Acute respiratory distress syndrome (ARDS) is a serious and potentially fatal acute inflammatory lung condition which currently has no specific treatments targeting its pathophysiology. However, mesenchymal stem cells have been shown to have very promising therapeutic potential, and recently, it has been established that their effect is largely due to the transfer of extracellular vesicles (EVs). EVs have been shown to transfer a variety of substances such as mRNA, miRNA, and even organelles such as mitochondria in order to ameliorate ARDS in preclinical models. In addition, the fact that they have been proven to have the same effect as their parent cells combined with their numerous advantages over whole cell administration means that they are a promising candidate for clinical application that merits further research.